Pancreatic cancer (PC) remains a lethal malignancy with limited treatment options.
The role of innate immune cell barrier-related genes in PC prognosis is poorly defined.
This study aimed to identify prognostic biomarkers, develop a predictive model, and uncover novel targets for personalized therapy.
